Hayat Pharmaceutical Industries Co (AMM:HPIC) Cyclically Adjusted Book per Share: JOD3.16 (As of Mar. 2026)


AMM:HPIC Hayat Pharmaceutical Industries Co AMM:HPIC
79 GF Score
Price JOD3.11
GF Value JOD2.74
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hayat Pharmaceutical Industries Co Cyclically Adjusted Book per Share?

Hayat Pharmaceutical Industries Co AMM:HPIC -0.64% 79 Cyclically Adjusted Book per Share is JOD3.16 as of Mar. 2026. GuruFocus rates AMM:HPIC with a GF Score™ of 79/100 and a GF Value™ of JOD2.74 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Hayat Pharmaceutical Industries Co's adjusted book value per share for the three months ended in Mar. 2026 was JOD3.286. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is JOD3.16 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Hayat Pharmaceutical Industries Co's average Cyclically Adjusted Book Growth Rate was 6.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Hayat Pharmaceutical Industries Co was 6.40% per year. The lowest was 6.40% per year. And the median was 6.40% per year.

As of today (2026-07-06), Hayat Pharmaceutical Industries Co's current stock price is JOD3.11. Hayat Pharmaceutical Industries Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was JOD3.16. Hayat Pharmaceutical Industries Co's Cyclically Adjusted PB Ratio of today is 0.98.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Hayat Pharmaceutical Industries Co was 1.67. The lowest was 0.87. And the median was 1.01.


Hayat Pharmaceutical Industries Co  (AMM:HPIC) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Hayat Pharmaceutical Industries Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.11/3.16
=0.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Hayat Pharmaceutical Industries Co was 1.67. The lowest was 0.87. And the median was 1.01.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Hayat Pharmaceutical Industries Co Cyclically Adjusted Book per Share Related Terms


Hayat Pharmaceutical Industries Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Hayat Pharmaceutical Industries Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hayat Pharmaceutical Industries Co Cyclically Adjusted Book per Share Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 2.56 2.72 2.89 3.08

Hayat Pharmaceutical Industries Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.96 3.01 3.06 3.08 3.16

AMM:HPIC vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hayat Pharmaceutical Industries Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hayat Pharmaceutical Industries Co's Cyclically Adjusted PB Ratio falls into.


AMM:HPIC
79GF Score
Hayat Pharmaceutical Industries Co AMM:HPIC
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hayat Pharmaceutical Industries Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hayat Pharmaceutical Industries Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.286/330.2130*330.2130
=3.286

Current CPI (Mar. 2026) = 330.2130.

Hayat Pharmaceutical Industries Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.779 241.018 2.437
201609 1.873 241.428 2.562
201612 1.934 241.432 2.645
201703 1.975 243.801 2.675
201706 1.946 244.955 2.623
201709 2.031 246.819 2.717
201712 2.069 246.524 2.771
201803 2.155 249.554 2.852
201806 2.114 251.989 2.770
201809 2.178 252.439 2.849
201812 2.300 251.233 3.023
201903 2.381 254.202 3.093
201906 2.314 256.143 2.983
201909 2.395 256.759 3.080
201912 2.517 256.974 3.234
202003 2.673 258.115 3.420
202006 2.690 257.797 3.446
202009 2.684 260.280 3.405
202012 2.787 260.474 3.533
202103 3.000 264.877 3.740
202106 2.857 271.696 3.472
202109 2.968 274.310 3.573
202112 2.970 278.802 3.518
202203 3.002 287.504 3.448
202206 2.884 296.311 3.214
202209 3.015 296.808 3.354
202212 3.092 296.797 3.440
202303 3.112 301.836 3.405
202306 2.868 305.109 3.104
202309 0.000 307.789 0.000
202312 3.087 306.746 3.323
202403 3.120 312.332 3.299
202406 3.013 314.175 3.167
202409 3.040 315.301 3.184
202412 3.247 315.605 3.397
202503 3.293 319.799 3.400
202506 3.110 322.561 3.184
202509 3.175 324.800 3.228
202512 3.270 324.054 3.332
202603 3.286 330.213 3.286

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of JOD3.16 mean?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Cyclically Adjusted Book per Share of JOD3.16 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Hayat Pharmaceutical Industries Co and its competitors.
Is Hayat Pharmaceutical Industries Co's Cyclically Adjusted Book per Share too high?
Hayat Pharmaceutical Industries Co's current Cyclically Adjusted Book per Share is JOD3.16. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Hayat Pharmaceutical Industries Co's Cyclically Adjusted Book per Share of JOD3.16 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Hayat Pharmaceutical Industries Co and its competitors. Hayat Pharmaceutical Industries Co's current Cyclically Adjusted Book per Share is JOD3.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co (AMM:HPIC) is currently considered Modestly Overvalued. The stock's GF Value™ is JOD2.74, compared to a current price of JOD3.11 — trading 13.5% above its estimated fair value. The current Cyclically Adjusted Book per Share is JOD3.16. Hayat Pharmaceutical Industries Co's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Cyclically Adjusted Book per Share is JOD3.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hayat Pharmaceutical Industries Co (AMM:HPIC) Overvalued in 2026?

Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co stock appears to be overvalued. The current stock price of JOD3.11 is trading 13.5% above its estimated GF Value™ of JOD2.74. GuruFocus considers Hayat Pharmaceutical Industries Co to be Modestly Overvalued.

Key valuation signals for AMM:HPIC:

  • Cyclically Adjusted Book per Share: JOD3.16
  • GF Value™: JOD2.74 vs. price of JOD3.11 (13.5% above fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the AMM:HPIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hayat Pharmaceutical Industries Co Business Description

Address Mohammed Ali Alkurdi St. Al-Rajeeb Amman, 1564 Amman, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
79GF Score

Get the complete analysis for AMM:HPIC

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD3.11
Price
JOD2.74
GF Value